SCI Pharmtech, Inc.
4119.TW
Price:
$49.3
Market Cap:
$5.89B
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty chemicals. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrog...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2004-01-07
Stock Exchange
TAI
Ticker
4119.TW
PE Ratio
[51.35]
ROE
[2.12%]
Current Ratio
[1.10]
Dividend Yield
[3.04%]
Enterprise Value
[6.78B]
Dividend History
The PE Ratio as of December 2025 (TTM) for SCI Pharmtech, Inc. (4119.TW) is 51.35
According to SCI Pharmtech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 51.35. This represents a change of -39.55% compared to the average of 84.94 of the last 4 quarters.
SCI Pharmtech, Inc. (4119.TW) Historical PE Ratio (quarterly & annually)
How has 4119.TW PE Ratio performed in the past?
The mean historical PE Ratio of SCI Pharmtech, Inc. over the last ten years is 33.19. The current 51.35 PE Ratio has changed 15.37% with respect to the historical average. Over the past ten years (40 quarters), 4119.TW's PE Ratio was at its highest in in the June 2021 quarter at 458.37. The PE Ratio was at its lowest in in the December 2023 quarter at -800.92.
Average
33.19
Median
19.39
Minimum
12.49
Maximum
143.86
SCI Pharmtech, Inc. (4119.TW) PE Ratio by Quarter and Year
Discovering the peaks and valleys of SCI Pharmtech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 675.89%
Maximum Annual PE Ratio = 143.86
Minimum Annual Increase = -79.06%
Minimum Annual PE Ratio = 12.49
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 20.25 | -43.53% |
| 2023 | 35.85 | 19.04% |
| 2022 | 30.12 | -79.06% |
| 2021 | 143.86 | 675.89% |
| 2020 | 18.54 | 22.22% |
| 2019 | 15.17 | 21.46% |
| 2018 | 12.49 | -47.73% |
| 2017 | 23.90 | 70.60% |
| 2016 | 14.01 | -20.85% |
| 2015 | 17.70 | 10.96% |
SCI Pharmtech, Inc. (4119.TW) Average PE Ratio
How has 4119.TW PE Ratio performed in the past?
The current PE Ratio of SCI Pharmtech, Inc. (4119.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
28.74
5-year avg
49.72
10-year avg
33.19
SCI Pharmtech, Inc. (4119.TW) PE Ratio vs. Peers
How is 4119.TW’s PE Ratio compared to its peers?
SCI Pharmtech, Inc.’s PE Ratio is greater than Pacific Hospital Supply Co., Ltd (15.33), greater than St.Shine Optical Co.,Ltd. (10.65), greater than Formosa Laboratories, Inc. (30.16), greater than Hi-Clearance Inc. (17.46), greater than Formosa Optical Technology Co.,Ltd. (14.66), greater than Orient Pharma Co., Ltd. (45.83), greater than SciVision Biotech Inc. (33.19), greater than Sinphar Pharmaceutical Co.,Ltd. (17.78), greater than OBI Pharma, Inc. (-3.05), greater than Mycenax Biotech Inc. (-13.72),
| Company | PE Ratio | Market cap |
|---|---|---|
| 15.33 | $6.25B | |
| 10.65 | $6.00B | |
| 30.16 | $7.28B | |
| 17.46 | $6.10B | |
| 14.66 | $6.13B | |
| 45.83 | $5.59B | |
| 33.19 | $5.38B | |
| 17.78 | $5.85B | |
| -3.05 | $7.35B | |
| -13.72 | $6.61B |
Build a custom stock screener for SCI Pharmtech, Inc. (4119.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SCI Pharmtech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
SCI Pharmtech, Inc. (4119.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like SCI Pharmtech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is SCI Pharmtech, Inc.'s PE Ratio?
How is the PE Ratio calculated for SCI Pharmtech, Inc. (4119.TW)?
What is the highest PE Ratio for SCI Pharmtech, Inc. (4119.TW)?
What is the 3-year average PE Ratio for SCI Pharmtech, Inc. (4119.TW)?
What is the 5-year average PE Ratio for SCI Pharmtech, Inc. (4119.TW)?
How does the current PE Ratio for SCI Pharmtech, Inc. (4119.TW) compare to its historical average?